The nation of Zimbabwe has turned down a significant US healthcare agreement valued at $367m (£272m) spanning five years because of Washington's request for sensitive information.
This move became public after a government memo dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesperson later explained that the United States was requesting biological samples for research and profit but was unwilling to share the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more negotiations to find a deal agreeable to both sides so the nation's critical HIV programme can proceed.
Wider Implications
Zimbabwe's decision comes after a similar case in Kenya, where a high court suspended a similar deal with the US after legal challenges were raised about the safety of citizens' health data.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government deals to boost openness and responsibility.
As per statements, 16 nations in Africa have so far agreed to similar health pacts, representing over $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership could have provided significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"In essence, our nation would supply the basic resources for scientific discovery with no assurance that the final treatments would be available to our people should a future health crisis arise."
Sovereignty and Global Health
He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures already established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage future global health emergencies.
"This mechanism is intended to guarantee that when a country provides its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," he added.
"We are open to further dialogue with our US partners on how subsequent collaboration could be designed in a manner that respects the sovereignty and dignity of both nations."
Medical Community Reaction
Medical experts expressed it understood the official position, but urged that talks must proceed since much of the nation's Aids initiatives depended on external financing.
"In cases where technical issues exist, including those involving information security or implementation frameworks, these can frequently be addressed via technical clarification and negotiated safeguards," it said.
This impasse emphasises the complex tensions between receiving crucial foreign assistance and safeguarding local interests in an increasingly interconnected world.